MSLN and familial pancreatic carcinoma: However, we have shown that stable overexpression of mesothelin in a pancreatic cancer cell line did not increase cell proliferation or anchorage- independent growth in vitro, suggesting that mesothelin is not necessarily a tumor progression factor [7].